Preparation method for serum miRNAs specific to active pulmonary tuberculosis
A pulmonary tuberculosis and active technology, applied in the field of molecular biology, can solve the problems of high cost, complicated sequencing operation, limited sequencing depth, etc., and achieve the effect of reducing the incidence rate.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Collection and clinical testing of serum samples from patients with active pulmonary tuberculosis and healthy controls:
[0024] A total of 80 patients with active pulmonary tuberculosis and 80 healthy controls were collected. The blood samples of all participants were drawn in the morning on an empty stomach, using disposable vacuum non-anticoagulant blood collection tubes, collecting 3.0mL of peripheral blood, centrifuging within 4 hours (3000x g, 10min, 4°C), aspiration of the supernatant, and aliquoting into 200μL each Serum samples were stored in a -80°C refrigerator.
Embodiment 2
[0026] Extract total RNA from all serum samples:
[0027] Take out the serum of patients with active pulmonary tuberculosis and healthy controls at -80°C, and let it dissolve naturally at 4°C; pipette 200 μL, add it to a 1.5mL RNase-free EP tube, add 700 μL Qiagen Lysis solution, and place in a vortex Vigorously vortex and mix until fully lysed, until no white suspension can be seen; stand at room temperature for 5 minutes; add 140 μL chloroform; mix vigorously for 15 seconds, and let stand for 3 minutes; ℃; Use a pipette to transfer the supernatant (about 500 μL) to a new 1.5 mL collection tube, add 1.5 times the volume of the supernatant in absolute ethanol, mix up and down; take 700 μL of ethanol-containing lysate and add it to the column In the middle, centrifuge at 8000g for 18s, discard the lower layer, reset the collection tube on the column (repeat 2 times); add 700μL RWT solution, centrifuge at 8000g for 18s, discard the lower layer, put the column on a new collection...
Embodiment 3
[0029] Example 3: High-throughput sequencing screening technology was used to initially screen differentially expressed miRNAs in the serum of patients with active pulmonary tuberculosis and healthy controls.
[0030] 20 cases of pulmonary tuberculosis patients and 20 cases of healthy controls each provided 20mL of serum; serum requirements: after detection by Agilent Bioanalyzer, the concentration is ≥5ng / ul, and the total amount is ≥100ng; there are few impurities such as protein and salt ions, and the separation by PAGE gel electrophoresis is relatively normal ;According to the results and bioinformatics software analysis, such as normalization and differential analysis calculation methods to select differentially expressed miRNAs; through clustering methods including hierarchical clustering, Kmeans clustering and SOM, etc. to classify different samples, and differentially expressed miRNAs Similarity analysis was performed to obtain differentially expressed serum miRNAs.
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap